Clinical trial
A Phase 2b, Randomized, Double-Blind, Multi-Dose Efficacy, Safety and Dose-finding Study of the Oral Factor Xa Inhibitor DU-176b Compared With Placebo for Prevention of Venous Thromboembolism in Patients After Total Knee Arthroplasty (STARS J-1)
NCT01203072 is registered in ClinicalTrials.gov with Daiichi Sankyo Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 2b, Randomized, Double-Blind, Multi-Dose Efficacy, Safety and Dose-finding Study of the Oral Factor Xa Inhibitor DU-176b Compared With Placebo for Prevention of Venous Thromboembolism in Patients After Total Knee Arthroplasty (STARS J-1)
- Lead sponsor
- Daiichi Sankyo Co., Ltd.
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- July 31, 2006
- Completion date
- July 31, 2008
- Enrollment
- 523 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
deep vein thrombosis, total knee arthroplasty, venous thromboembolism